CLEVELAND–(BUSINESS WIRE)– Medical device and technology company Lazurite Holdings LLC announced that it will exhibit its new modular ArthroFree™ wireless arthroscopic camera system at two upcoming events: the annual meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Aug. 31-Sept. 3, 2021 (Booth 5312); and the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) in Las Vegas, also Aug. 31-Sept. 3, 2021 (Booth 241). At SAGES, Lazurite will be one of three finalists competing for a $30,000 first prize in the SAGES Shark Tank 2021. Attendees also will be eligible to vote.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210823005372/en/
The novel ArthroFree™ platform, when approved, is expected to be the world’s first FDA approved fully wireless, minimally invasive modular camera system for the operating room, featuring the patented Meridiem™ light engine. (Photo: Business Wire)
Pre-production demo models of the ArthroFree wireless system will be available for surgeons and physicians to try out for themselves at both meetings. Lazurite’s leadership and development teams will be onsite to discuss the new system and address questions. AAOS is expected to attract thousands of attendees; SAGES expects approximately 1,500 attendees.
“We are excited to introduce our ArthroFree wireless camera system at both the upcoming AAOS and SAGES meetings,” said Eugene Malinskiy, Chief Executive Officer and founder of Lazurite. “AAOS is the largest convention of orthopedic surgeons in North America, so it is an ideal venue to exhibit our device. We believe orthopedic surgeons, along with the facilities where they practice, will find the system to be innovative and offer multiple avenues to add value to their practices and facilities.
“We are looking forward to exhibiting at SAGES and competing in the finals of its Shark Tank competition. While orthopedics is our initial target market, the ArthroFree system is designed for compatibility with various flexible and rigid endoscopes, as well as surgical tower systems that are applicable to gastroenterology, laparoscopy, and the wider endoscopic market. The modular system is designed to be fully drop-in compatible with current operating room technology across specialty areas.’’
The ArthroFree system is expected to be the world’s first FDA-approved fully wireless, minimally invasive camera system for the operating room. It incorporates Lazurite’s proprietary low heat, high intensity Meridiem™ light engine technology with advanced camera, battery, and wireless transmission technologies. The system is designed to deliver improved OR productivity, patient safety, and economic value through cost-savings, energy efficiency, and reduced setup/breakdown times.
Mark Froimson, MD, Chair of the Board of Managers of Lazurite, said, “We are looking forward to introducing ArthroFree to the orthopedic and gastrointestinal surgeons attending these two important conferences. It’s always exciting to see the reaction when surgeons first experience this game-changing, innovative technology. They routinely tell us that ArthroFree’s wireless, user-friendly design is long overdue, and that they look forward to utilizing it in their ORs.”
The ArthroFree™ wireless arthroscopic camera system has not yet received FDA clearance and is not currently approved for human use. It is not intended for commercial distribution; orders cannot be accepted at this time.
Lazurite (formerly Indago) is a pre-revenue medical device startup company backed by private capital. The company has raised more than $18 million to date from institutional investors, family offices, and more than 50 physician champions. Founded in Cleveland in 2015, Lazurite has developed novel technology that will enable it to create the operating room of the future. The company’s product pipeline features the modular ArthroFree™ wireless surgical camera system, which is expected to be the first FDA-approved fully wireless minimally invasive camera system platform designed for the operating room, and other innovative new products based on the company’s novel and patented Meridiem™ light engine technology. Lazurite’s technologies are protected by a comprehensive intellectual property portfolio encompassing our ArthroFree wireless surgical camera system and our novel MeridiemTM light source as well as other products currently in development. For more information, see: https://lazurite.co.
About SAGES Shark Tank 2021
In keeping with its mission to innovate, educate, and collaborate to improve patient care, SAGES is launching a three-pronged initiative to educate its members on entrepreneurism, engage and showcase inventors through the reimagined and funded SAGES Shark Tank business competition. This year’s Shark Tank finalists will present to a panel of three judges before a live audience of 200-300. The winning company will receive a $30,000 first prize. Attendees who register for and attend a postgraduate-level course on innovation and investment on Wednesday, Sept 1, will be eligible to vote for the winning pitch. For more information, see: sages2021.surgery/shark-tank.
Forward Looking Statements
This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “milestone,” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding our regulatory submission timeline for ArthroFree™. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Lazurite™, ArthroFree™, and Meridiem™ are trademarks of Lazurite Holdings LLC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210823005372/en/
Source: Lazurite Holdings LLC